Загрузка...
Need to improve clinical trials in rare neurodegenerative disorders
Rare neurodegenerative diseases are fatal and no therapy is available to cure or slow down the progression of disease. We report possibly weaknesses in the management of clinical studies in these diseases, ranging from poor preclinical studies, difficulties in the recruitment of patients, delay in t...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Istituto Superiore di Sanità
2011-01-01
|
| Серии: | Annali dell'Istituto Superiore di Sanità |
| Предметы: | |
| Online-ссылка: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0021-25712011000100012&lng=en&tlng=en |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|